HD21 for Advanced Stages

NCT02661503 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Classical Hodgkin Lymphoma

Interventions

DRUG: Bleomycin
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Procarbazine
DRUG: Prednisone
DRUG: Brentuximab Vedotin
DRUG: Dacarbazine
DRUG: Dexamethasone

Sponsor

University of Cologne